Compare Globus Medical Inc. Class A Common Stock (GMED) vs Snowflake Inc (SNOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Snowflake Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Snowflake Inc trades at $330.2 (market cap $126.22B). The key difference: Snowflake Inc is far larger — about 12.3× Globus Medical Inc. Class A Common Stock's market cap, and Snowflake Inc is trading nearer its 52-week high, Globus Medical Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Snowflake Inc for 53 Days on average.
| GMED | SNOW | |
|---|---|---|
Market Cap | $10.25B | $126.22B |
Volume | 1,108,124 | 4,112,138 |
Sector | Health | Technology |
52-Week High | $96.82 | $368.89 |
52-Week Low | $58.33 | $121.11 |
Typical Hold Time | 0 Days | 53 Days |
Enterprise Value | $9.76B | $126.64B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Snowflake (SNOW) trades at $335.08, down 7.02% amid market volatility, but maintains strong analyst support with 81% buy ratings and a $418.03 consensus target. The company shows robust revenue growth, reaching $3.63 billion in 2025, though it remains unprofitable with a -20.07% net margin. Recent technical indicators are bullish on moving averages, while oscillators remain neutral. Key developments include a $3.75 billion convertible note offering and expanded partnerships with UiPath.
Outlook remains positive given strong revenue trajectory and analyst confidence, but risks include persistent losses, high valuation multiples (P/S 22.66), and competitive pressures. The stock offers growth potential if profitability improves, yet investors must weigh execution risks against long-term AI data cloud opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →
